pre-miRNA Information
pre-miRNA hsa-mir-499a   
Genomic Coordinates chr20: 34990376 - 34990497
Description Homo sapiens miR-499a stem-loop
Comment The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-499a-3p
Sequence 70| AACAUCACAGCAAGUCUGUGCU |91
Evidence Experimental
Experiments Cloned
DRVs in miRNA
Mutant ID Mutant Position Mutant Source
COSN30512073 1 COSMIC
COSN8868602 4 COSMIC
COSN20079766 19 COSMIC
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs768246420 3 dbSNP
rs3746444 4 dbSNP
rs761417578 6 dbSNP
rs150018420 8 dbSNP
rs1406470841 9 dbSNP
rs772652105 11 dbSNP
rs1189840352 16 dbSNP
rs759966338 17 dbSNP
rs1475405341 21 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol TSC22D3   
Synonyms DIP, DSIPI, GILZ, TSC-22R
Description TSC22 domain family member 3
Transcript NM_198057   
Other Transcripts NM_004089 , NM_001015881   
Expression
Putative miRNA Targets on TSC22D3
3'UTR of TSC22D3
(miRNA target sites are highlighted)
>TSC22D3|NM_198057|3'UTR
   1 GTGGCTCTGTCCTCAGGGTGGGCAGAGCCACTAAACTTGTTTTACCTAGTTCTTTCCAGTTTGTTTTTGGCTCCCCAAGC
  81 ATCATCTCACGAGGAGAACTTTACACCTAGCACAGCTGGTGCCAAGAGATGTCCTAAGGACATGGCCACCTGGGTCCACT
 161 CCAGCGACAGACCCCTGACAAGAGCAGGTCTCTGGAGGCTGAGTTGCATGGGGCCTAGTAACACCAAGCCAGTGAGCCTC
 241 TAATGCTACTGCGCCCTGGGGGCTCCCAGGGCCTGGGCAACTTAGCTGCAACTGGCAAAGGAGAAGGGTAGTTTGAGGTG
 321 TGACACCAGTTTGCTCCAGAAAGTTTAAGGGGTCTGTTTCTCATCTCCATGGACATCTTCAACAGCTTCACCTGACAACG
 401 ACTGTTCCTATGAAGAAGCCACTTGTGTTTTAAGCAGAGGCAACCTCTCTCTTCTCCTCTGTTTCGTGAAGGCAGGGGAC
 481 ACAGATGGGAGAGATTGAGCCAAGTCAGCCTTCTGTTGGTTAATATGGTATAATGCATGGCTTTGTGCACAGCCCAGTGT
 561 GGGATTACAGCTTTGGGATGACCGCTTACAAAGTTCTGTTTGGTTAGTATTGGCATAGTTTTTCTATATAGCCATAAATG
 641 CGTATATATACCCATAGGGCTAGATCTGTATCTTAGTGTAGCGATGTATACATATACACATCCACCTACATGTTGAAGGG
 721 CCTAACCAGCCTTGGGAGTATTGACTGGTCCCTTACCTCTTATGGCTAAGTCTTTGACTGTGTTCATTTACCAAGTTGAC
 801 CCAGTTTGTCTTTTAGGTTAAGTAAGACTCGAGAGTAAAGGCAAGGAGGGGGGCCAGCCTCTGAATGCGGCCACGGATGC
 881 CTTGCTGCTGCAACCCTTTCCCCAGCTGTCCACTGAAACGTGAAGTCCTGTTTTGAATGCCAAACCCACCATTCACTGGT
 961 GCTGACTACATAGAATGGGGTTGAGAGAAGATCAGTTTGGGCTTCACAGTGTCATTTGAAAACGTTTTTTGTTTTGTTTT
1041 GTAATTATTGTGGAAAACTTTCAAGTGAACAGAAGGATGGTGTCCTACTGTGGATGAGGGATGAACAAGGGGATGGCTTT
1121 GATCCAATGGAGCCTGGGAGGTGTGCCCAGAAAGCTTGTCTGTAGCGGGTTTTGTGAGAGTGAACACTTTCCACTTTTTG
1201 ACACCTTATCCTGATGTATGGTTCCAGGATTTGGATTTTGATTTTCCAAATGTAGCTTGAAATTTCAATAAACTTTGCTC
1281 TGTTTTTCTAAAAATAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' ucGUGUCUGA--ACG--ACACUACAa 5'
            ||||| ||  |||   | ||||| 
Target 5' agCACAG-CTGGTGCCAAGAGATGTc 3'
109 - 133 127.00 -14.20
2
miRNA  3' ucgUGUCUGAACGACACUACAa 5'
             |||  ||| :  |||||| 
Target 5' ttgACA-CCTTATCCTGATGTa 3'
1198 - 1218 122.00 -6.50
3
miRNA  3' ucGUGUCUGAACGACACUACAa 5'
            | :||   ||: | ||||| 
Target 5' atCTTAG---TGTAGCGATGTa 3'
670 - 688 117.00 -6.20
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1275816911 4 dbSNP
rs1204187005 5 dbSNP
rs1017346716 8 dbSNP
rs761271427 16 dbSNP
rs773556062 18 dbSNP
rs772604324 19 dbSNP
rs1377421531 20 dbSNP
rs748514130 23 dbSNP
rs1411290120 27 dbSNP
rs1350651982 29 dbSNP
rs774692162 33 dbSNP
rs1439739278 36 dbSNP
rs1452436659 46 dbSNP
rs1001650552 47 dbSNP
rs1412650462 51 dbSNP
rs1297503687 64 dbSNP
rs1326927048 70 dbSNP
rs1243855119 76 dbSNP
rs903807688 83 dbSNP
rs1249552098 84 dbSNP
rs758212082 90 dbSNP
rs1212247995 91 dbSNP
rs773909537 104 dbSNP
rs945252394 106 dbSNP
rs1315674228 116 dbSNP
rs771280473 118 dbSNP
rs1484511086 126 dbSNP
rs189584221 129 dbSNP
rs1262944426 141 dbSNP
rs1045584129 149 dbSNP
rs944100953 150 dbSNP
rs1356260886 157 dbSNP
rs1454725381 174 dbSNP
rs1173122134 186 dbSNP
rs1373834722 188 dbSNP
rs949865698 191 dbSNP
rs1290397857 215 dbSNP
rs1311064864 222 dbSNP
rs1381455308 249 dbSNP
rs891718565 253 dbSNP
rs1373139885 261 dbSNP
rs764613224 262 dbSNP
rs985391454 300 dbSNP
rs1345280787 307 dbSNP
rs1381540078 310 dbSNP
rs12689231 325 dbSNP
rs1240831289 334 dbSNP
rs1260949145 340 dbSNP
rs1485711496 351 dbSNP
rs1203776315 352 dbSNP
rs1302927035 353 dbSNP
rs1469337402 361 dbSNP
rs1193062514 369 dbSNP
rs1052932139 377 dbSNP
rs1449517570 382 dbSNP
rs1393409672 391 dbSNP
rs778279639 399 dbSNP
rs770407980 400 dbSNP
rs1363464535 404 dbSNP
rs775650103 409 dbSNP
rs974793168 410 dbSNP
rs1452736728 415 dbSNP
rs920214250 428 dbSNP
rs943161852 429 dbSNP
rs765303619 454 dbSNP
rs1441625384 460 dbSNP
rs374793446 465 dbSNP
rs987004835 466 dbSNP
rs1224977766 472 dbSNP
rs974719596 495 dbSNP
rs1315995898 508 dbSNP
rs1237291453 509 dbSNP
rs1275495029 526 dbSNP
rs961582459 536 dbSNP
rs1213693176 549 dbSNP
rs184402083 554 dbSNP
rs759793687 570 dbSNP
rs955484309 583 dbSNP
rs1161367767 584 dbSNP
rs1444272536 599 dbSNP
rs1414741664 610 dbSNP
rs1177885689 615 dbSNP
rs776769844 625 dbSNP
rs770822966 626 dbSNP
rs1417609195 629 dbSNP
rs1156673673 639 dbSNP
rs34394281 639 dbSNP
rs962937806 641 dbSNP
rs960412421 642 dbSNP
rs748709200 645 dbSNP
rs1164056548 659 dbSNP
rs781387051 663 dbSNP
rs1348069951 668 dbSNP
rs1443687714 670 dbSNP
rs1033421666 682 dbSNP
rs1242112390 683 dbSNP
rs1407674589 688 dbSNP
rs1295494936 689 dbSNP
rs1356423525 692 dbSNP
rs1217114563 704 dbSNP
rs1016965412 705 dbSNP
rs903502093 707 dbSNP
rs1290046818 720 dbSNP
rs755136930 734 dbSNP
rs1043677159 741 dbSNP
rs1009868684 757 dbSNP
rs1001914804 760 dbSNP
rs1245645158 773 dbSNP
rs1258505856 776 dbSNP
rs970187881 777 dbSNP
rs1024773589 780 dbSNP
rs201659549 781 dbSNP
rs1014051889 790 dbSNP
rs1229605265 794 dbSNP
rs1359243143 795 dbSNP
rs1353484818 811 dbSNP
rs757390303 827 dbSNP
rs944132117 830 dbSNP
rs1400543255 831 dbSNP
rs1414518778 835 dbSNP
rs1282844410 840 dbSNP
rs1364683237 848 dbSNP
rs780151730 849 dbSNP
rs1213144864 851 dbSNP
rs181782850 853 dbSNP
rs1485488490 854 dbSNP
rs1423741441 859 dbSNP
rs912678942 863 dbSNP
rs1476348600 869 dbSNP
rs1000090245 873 dbSNP
rs1418725624 874 dbSNP
rs1049796125 875 dbSNP
rs1350725836 879 dbSNP
rs1375654376 881 dbSNP
rs932676523 887 dbSNP
rs1332607230 904 dbSNP
rs1347254122 910 dbSNP
rs1431953359 920 dbSNP
rs1167169344 923 dbSNP
rs760578858 930 dbSNP
rs1236545087 944 dbSNP
rs974372482 946 dbSNP
rs1347406734 947 dbSNP
rs1217756502 958 dbSNP
rs1038710194 961 dbSNP
rs943005244 971 dbSNP
rs13194 978 dbSNP
rs7052295 983 dbSNP
rs1267321379 985 dbSNP
rs1216262159 995 dbSNP
rs1222272430 1018 dbSNP
rs1247310474 1023 dbSNP
rs908719864 1024 dbSNP
rs1194943861 1031 dbSNP
rs1051547534 1037 dbSNP
rs1453276079 1052 dbSNP
rs763936198 1061 dbSNP
rs1409740783 1073 dbSNP
rs1401614074 1080 dbSNP
rs1490605541 1082 dbSNP
rs960863977 1089 dbSNP
rs1355036342 1094 dbSNP
rs760584096 1096 dbSNP
rs929038845 1105 dbSNP
rs55822441 1111 dbSNP
rs766975380 1117 dbSNP
rs972883742 1124 dbSNP
rs1305337814 1128 dbSNP
rs962970685 1140 dbSNP
rs1434417428 1143 dbSNP
rs772149832 1162 dbSNP
rs1342346100 1165 dbSNP
rs1281267360 1166 dbSNP
rs1404177826 1167 dbSNP
rs75970188 1174 dbSNP
rs967718861 1178 dbSNP
rs758993128 1185 dbSNP
rs189325652 1186 dbSNP
rs1009489175 1187 dbSNP
rs970430783 1200 dbSNP
rs1450492080 1201 dbSNP
rs892341611 1202 dbSNP
rs1049740 1203 dbSNP
rs372914288 1209 dbSNP
rs1234222545 1215 dbSNP
rs747547446 1221 dbSNP
rs1158867832 1227 dbSNP
rs184308029 1247 dbSNP
rs1460661980 1251 dbSNP
rs1014329843 1264 dbSNP
rs1463348288 1270 dbSNP
rs1166211733 1272 dbSNP
rs1394423094 1277 dbSNP
rs1403635718 1281 dbSNP
rs4351535 1288 dbSNP
rs111358152 1290 dbSNP
rs1008721723 1295 dbSNP
rs1171501462 1296 dbSNP
rs1467225637 1299 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Disease 1831.0
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1 ...

- Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' ucgugucUGAACGACACUacaa 5'
                 ||||  | |||    
Target 5' acuuuccACUU--UUUGAcacc 3'
4 - 23
Article - Kishore S; Jaskiewicz L; Burger L; Hausser et al.
- Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' ucgugucUGAACGACACUacaa 5'
                 ||||  | |||    
Target 5' acuuuccACUU--UUUGAcacc 3'
4 - 23
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM714644
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / completeT1, repA
Location of target site ENST00000372390.4 | 3UTR | AACACUUUCCACUUUUUGACACCUUAUCCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 21572407 / GSE28865
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000372390.4 | 3UTR | AACACUUUCCACUUUUUGACACCUUAUCCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
GSE28544 Breast cancer 0.648 3.1e-4 0.652 2.8e-4 24 Click to see details
GSE32688 Pancreatic cancer 0.275 6.4e-2 0.272 6.6e-2 32 Click to see details
GSE28260 Renal cortex and medulla -0.408 8.3e-2 -0.543 2.8e-2 13 Click to see details
GSE19350 CNS germ cell tumors -0.314 1.6e-1 0.002 5.0e-1 12 Click to see details
GSE17498 Multiple myeloma 0.147 1.8e-1 0.031 4.2e-1 40 Click to see details
GSE42095 Differentiated embryonic stem cells -0.195 1.9e-1 -0.208 1.7e-1 23 Click to see details
GSE34608 Pulmonary tuberculosis and sarcoidosis 0.192 2.1e-1 0.053 4.1e-1 20 Click to see details
GSE38226 Liver fibrosis 0.15 2.6e-1 -0.099 3.3e-1 21 Click to see details
GSE38974 Chronic obstructive pulmonary disease -0.134 2.6e-1 0.027 4.5e-1 25 Click to see details
GSE21687 Ependynoma primary tumors -0.018 4.4e-1 -0.088 2.4e-1 64 Click to see details
GSE26953 Aortic valvular endothelial cells -0.03 4.4e-1 -0.067 3.8e-1 24 Click to see details
GSE26953 Aortic valvular endothelial cells -0.03 4.4e-1 -0.067 3.8e-1 24 Click to see details
GSE26953 Aortic valvular endothelial cells -0.03 4.4e-1 -0.067 3.8e-1 24 Click to see details
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
STAD -0.997 0 -1.000 0.5 5 Click to see details
HNSC 0.434 0.12 0.450 0.11 9 Click to see details
LIHC -0.278 0.14 -0.152 0.28 17 Click to see details
BRCA -0.826 0.19 -0.500 0.33 3 Click to see details
UCEC -0.358 0.22 -0.250 0.29 7 Click to see details
PRAD -0.146 0.31 -0.099 0.37 14 Click to see details
KIRC 0.093 0.35 0.291 0.11 19 Click to see details
LUSC -0.238 0.38 -0.400 0.3 4 Click to see details
KICH -0.1 0.39 0.018 0.48 10 Click to see details
KIRP 0.04 0.46 0.133 0.37 9 Click to see details
THCA -0.005 0.49 -0.049 0.4 29 Click to see details
THCA -0.005 0.49 -0.049 0.4 29 Click to see details
THCA -0.005 0.49 -0.049 0.4 29 Click to see details
THCA -0.005 0.49 -0.049 0.4 29 Click to see details
THCA -0.005 0.49 -0.049 0.4 29 Click to see details
59 hsa-miR-499a-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT130131 TXNIP thioredoxin interacting protein 2 2
MIRT133678 ETNK1 ethanolamine kinase 1 2 2
MIRT252103 NAPG NSF attachment protein gamma 2 2
MIRT260160 IGFBP4 insulin like growth factor binding protein 4 2 2
MIRT388009 DR1 down-regulator of transcription 1 2 2
MIRT441692 ABLIM1 actin binding LIM protein 1 2 6
MIRT447799 EPC2 enhancer of polycomb homolog 2 2 2
MIRT450657 STYX serine/threonine/tyrosine interacting protein 2 4
MIRT456843 ZNF460 zinc finger protein 460 2 2
MIRT464134 VPS35 VPS35, retromer complex component 2 2
MIRT465101 TSC22D3 TSC22 domain family member 3 2 4
MIRT470051 PTGFRN prostaglandin F2 receptor inhibitor 2 2
MIRT474146 LIMA1 LIM domain and actin binding 1 2 6
MIRT474153 LIFR LIF receptor alpha 2 2
MIRT485327 MYO1D myosin ID 2 2
MIRT496403 ZSCAN16 zinc finger and SCAN domain containing 16 2 2
MIRT497280 MAF MAF bZIP transcription factor 2 2
MIRT500970 SPTSSA serine palmitoyltransferase small subunit A 2 2
MIRT501536 POM121C POM121 transmembrane nucleoporin C 2 6
MIRT505174 WDR76 WD repeat domain 76 2 4
MIRT505203 UQCRB ubiquinol-cytochrome c reductase binding protein 2 4
MIRT506745 LIN54 lin-54 DREAM MuvB core complex component 2 4
MIRT506799 KLHL15 kelch like family member 15 2 6
MIRT525718 DCAF12L2 DDB1 and CUL4 associated factor 12 like 2 2 2
MIRT530014 SRRM1 serine and arginine repetitive matrix 1 2 2
MIRT531457 PROSER2 proline and serine rich 2 2 2
MIRT532272 CD93 CD93 molecule 2 2
MIRT538715 CAPRIN2 caprin family member 2 2 4
MIRT547356 NAT8L N-acetyltransferase 8 like 2 2
MIRT551468 TRIM59 tripartite motif containing 59 2 2
MIRT555444 NT5C3A 5'-nucleotidase, cytosolic IIIA 2 2
MIRT555674 PGAM4 phosphoglycerate mutase family member 4 2 4
MIRT557816 FOXO1 forkhead box O1 2 2
MIRT557853 FIGN fidgetin, microtubule severing factor 2 2
MIRT557880 FEM1B fem-1 homolog B 2 4
MIRT562299 GLO1 glyoxalase I 2 2
MIRT563245 QRFPR pyroglutamylated RFamide peptide receptor 2 2
MIRT565571 SLC7A2 solute carrier family 7 member 2 2 2
MIRT566214 PTMA prothymosin, alpha 2 2
MIRT575544 Map4 microtubule-associated protein 4 2 2
MIRT609316 FXYD6 FXYD domain containing ion transport regulator 6 2 2
MIRT609362 ACOT2 acyl-CoA thioesterase 2 2 2
MIRT611163 BTLA B and T lymphocyte associated 2 4
MIRT611749 CACNA1B calcium voltage-gated channel subunit alpha1 B 2 2
MIRT615019 ELK4 ELK4, ETS transcription factor 2 2
MIRT623317 MAPK1 mitogen-activated protein kinase 1 2 2
MIRT624550 BMPR1A bone morphogenetic protein receptor type 1A 2 2
MIRT633934 DNAH9 dynein axonemal heavy chain 9 2 2
MIRT635691 BMP10 bone morphogenetic protein 10 2 2
MIRT646438 DNAH8 dynein axonemal heavy chain 8 2 2
MIRT651940 UBN1 ubinuclein 1 2 2
MIRT663605 TBC1D22A TBC1 domain family member 22A 2 2
MIRT689759 PRR13 proline rich 13 2 2
MIRT691916 SRXN1 sulfiredoxin 1 2 2
MIRT698678 TEF TEF, PAR bZIP transcription factor 2 2
MIRT700924 PDS5A PDS5 cohesin associated factor A 2 2
MIRT707970 PDE12 phosphodiesterase 12 2 2
MIRT715290 CSTF1 cleavage stimulation factor subunit 1 2 2
MIRT722414 RARS2 arginyl-tRNA synthetase 2, mitochondrial 2 2
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-499a Erlotinib 176870 NSC718781 approved sensitive Low Osteosarcoma cell line (CD166)
hsa-mir-499a Cisplatin 5460033 NSC119875 approved resistant Low Cervical Cancer cell line (GH329, Hela, CaSki, Siha)
hsa-miR-499a-3p Trametinib 11707110 NSC758246 approved sensitive High Melanoma cell line (M14) (2uM)
hsa-miR-499a-3p Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (M14) (2uM)
hsa-miR-499a-3p Gefitinib 123631 NSC715055 approved resistant cell line (HCC827)
hsa-miR-499a-3p Osimertinib 71496458 NSC779217 approved resistant cell line (HCC827)
hsa-miR-499a-3p Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-miR-499a-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM47)
hsa-miR-499a-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM36)
hsa-miR-499a-3p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-499a-3p Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-499a-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-499a-3p Cisplatin 5460033 NSC119875 approved resistant cell line (A2780)
hsa-miR-499a-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)

Error report submission